Table 1.

Classification conditions of EGFR inhibitor samples.

Drug	Sensitivity	Resistance	No. of Sensitive Cell Lines	No. of Resistance Cell Lines
WZ8040	>0 & <10.5	>12	22	27
WZ4002	>0 & <12	>13	18	28
Vandetanib	>0 & <11.5	>13.5	25	26
PD-153035	>0 & <12.5	>14.5	19	21
Neratinib	>0 & <10	>13	24	33
Lapatinib	>0 & <11.5	>14	21	24
Gefitinib	>0 & <11	>13.5	19	21
Erlotinib	>0 & <11.5	>14.5	19	21
Canertinib	>0 & <10	>13	21	33
Afatinib	>0 & <9	>11.5	27	30